2005 article on the coronavirus and patents with CRUCELL, now owned by Johnson and Johnson who bid on the company in 2012 for 2.3 billion.
Gets better…..
The CDC, NIH & Bill Gates Own the Patents On Existing Ebola & Related Vaccines: Mandatory Vaccinations Are Near
http://theglobalelite.org/cdc-nih-bill-gates-patents-existing-ebola-related-vaccines-mandatory-vaccinations-near/
Compositions against SARS-coronavirus and uses thereof
Nov 10, 2005 - Crucell Holland B.V.
The present invention provides compositions of binding molecules specifically binding to a coronavirus such as SARS-CoV and capable of neutralizing an infection caused by the virus. The compositions are suitable for diagnosing, preventing and/or treating a condition resulting from a coronavirus such as SARS-CoV.
Latest Crucell Holland B.V. Patents:
Human binding molecules capable of neutralizing influenza virus H3N2 and uses thereof
FORMULATIONS FOR VIROSOMES
PROCESS FOR PREPARING INFLUENZA VACCINES
Method for the production and purification of adenoviral vectors
Anti-human respiratory syncytial virus (RSV) antibodies and methods of use
Skip to: Description · Claims · References Cited · Patent History · Patent History
Description
CROSS-REFERENCE TO RELATED APPLICATIONS
This is a national phase entry under 35 U.S.C. §371 of International Patent Application PCT/EP2005/055876, filed Nov. 10, 2005, published in English as International Patent Publication WO 2006/051091 A1 on May 18, 2006, which claims the benefit under 35 U.S.C. §119 of European Patent Application Serial No. 05107288.2 filed on Aug. 8, 2005, which claims priority to European Patent Application Serial No. 05102117.8 filed on Mar. 17, 2005, which claims priority to European Patent Application Serial No. 04106192.0 filed on Nov. 30, 2004, which claims priority to U.S. Provisional Patent Application Ser. No. 60/627,773, filed Nov. 11, 2004, and to European Patent Application Serial No. 04105684.7, filed Nov. 11, 2004.
TECHNICAL FIELD
The invention relates to medicine. In particular, the invention relates to compositions comprising binding molecules capable of specifically binding to and neutralizing SARS-coronavirus (SARS-CoV). The compositions are useful in the diagnosis of SARS-CoV and the prophylaxis and/or treatment of a condition resulting from SARS-CoV.
Sauce
https://patents.justia.com/patent/8106170
THE ARTICLE IS LENGTHY